Michael Nicholson
President chez Inceptor Bio LLC
Profil
Michael G.
Nicholson is currently the President & Chief Operating Officer at Inceptor Bio LLC and an Advisor at Specific Biologics, Inc. He previously worked as the Director-Cell Biology at Precision BioSciences, Inc. and as the Chief Development Officer at N-Viro International Corp.
from 2004 to 2007.
He holds a doctorate degree from The Johns Hopkins University and an undergraduate degree from The State University of New York.
Postes actifs de Michael Nicholson
| Sociétés | Poste | Début |
|---|---|---|
Inceptor Bio LLC
 Inceptor Bio LLC BiotechnologyHealth Technology Inceptor Bio LLC operates as a biotechnology industry company. The company is headquartered in Raleigh, NC. | President | - |
Specific Biologics, Inc.
 Specific Biologics, Inc. Miscellaneous Commercial ServicesCommercial Services Specific Biologics, Inc. is a biotechnology company that focuses on developing gene editing technologies to treat diseases through precision gene editing. The company is based in Toronto, Canada. The Canadian company's two-site dualase™ platform gene editors cut DNA in a way that optimally exploits the cells naturally occurring DNA repair pathways, enabling two gene editing outcomes, precise DNA deletions to disrupt genes or increased repair to correct genes. Specific also develops lipid nanoparticles to deliver the gene editor to target cells and is developing a pipeline of dualase™-based therapeutics in areas of high unmet medical need. The company was founded in 2017. The CEO is Brent Stead. | Consultant / Advisor | 24/07/2023 |
Anciens postes connus de Michael Nicholson
| Sociétés | Poste | Fin |
|---|---|---|
| N-VIRO INTERNATIONAL CORPORATION | Corporate Officer/Principal | 07/06/2007 |
| PRECISION BIOSCIENCES, INC. | Human Resources Officer | - |
Formation de Michael Nicholson
| The Johns Hopkins University | Doctorate Degree |
| The State University of New York | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| PRECISION BIOSCIENCES, INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
N-Viro International Corp.
 N-Viro International Corp. Industrial SpecialtiesProcess Industries N-Viro International Corp. is a technology, service, and process handling company, which engages in conversion process of bioorganic materials. It integrates technology with its alternative energy product, N-Viro Fuel for commercial applications. The company also owns and licenses various N-Viro processes and patented technologies to treat and recycle wastewater and other bio-organic wastes, utilizing certain alkaline and mineral by-products produced by the cement, lime, electrical generation and other industries. N-Viro International was founded in April 1993 and is headquartered in Toledo, OH. | Process Industries |
Inceptor Bio LLC
Inceptor Bio LLC BiotechnologyHealth Technology Inceptor Bio LLC operates as a biotechnology industry company. The company is headquartered in Raleigh, NC. | Health Technology |
Specific Biologics, Inc.
Specific Biologics, Inc. Miscellaneous Commercial ServicesCommercial Services Specific Biologics, Inc. is a biotechnology company that focuses on developing gene editing technologies to treat diseases through precision gene editing. The company is based in Toronto, Canada. The Canadian company's two-site dualase™ platform gene editors cut DNA in a way that optimally exploits the cells naturally occurring DNA repair pathways, enabling two gene editing outcomes, precise DNA deletions to disrupt genes or increased repair to correct genes. Specific also develops lipid nanoparticles to deliver the gene editor to target cells and is developing a pipeline of dualase™-based therapeutics in areas of high unmet medical need. The company was founded in 2017. The CEO is Brent Stead. | Commercial Services |
